Login / Signup
Intriguing findings on lebrikizumab for treating moderate-to-severe atopic dermatitis.
Bernd W M Arents
Published in:
The British journal of dermatology (2023)
Keyphrases
</>
atopic dermatitis
high intensity
early onset
drug induced